Capstone Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
$213K Sell
2,698
-110
-4% -$8.68K 0.01% 1482
2017
Q1
$233K Sell
2,808
-200
-7% -$16.6K 0.01% 1458
2016
Q4
$239K Sell
3,008
-3,492
-54% -$277K 0.01% 1468
2016
Q3
$455K Buy
+6,500
New +$455K 0.01% 1030